SCHEMBL6710087

SCHEMBL6710087

CCC(=O)Nc1cccc2cc(C(=O)Nc3ccc(Cl)cc3-c3nnn[nH]3)[nH]c12

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PLCG2 P16885 1/20 0.39
POLB P06746 3/20 0.38
LMNA P02545 3/20 0.38
MAPT P10636 2/20 0.38
TP53 P04637 2/20 0.38
NHERF1 O14745 2/20 0.38
PTK2B Q14289 1/20 0.38
MAPK1 P28482 1/20 0.37
TDP1 Q9NUW8 1/20 0.37
ALOX15 P16050 1/20 0.37
ALDH1A1 P00352 2/20 0.37
SMN1; SMN2 Q16637 2/20 0.37
NPC1 O15118 1/20 0.37
RAB9A P51151 1/20 0.37
MAP3K5 Q99683 1/20 0.36
PARP14 Q460N5 1/20 0.36
MEN1 O00255 2/20 0.35
KMT2A Q03164 2/20 0.35
KDM4E B2RXH2 1/20 0.35
F10 P00742 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6710315 0.93 POLB (0.39) PLCG2POLBLMNAMAPTTP53
SCHEMBL6707884 0.92 HDAC3 (0.40) PLCG2POLBLMNAMAPTTP53
SCHEMBL6709211 0.91 PLCG2 (0.39) PLCG2POLBLMNAMAPTTP53
SCHEMBL6714199 0.91 HDAC3 (0.41) PLCG2POLBLMNAMAPTTP53
SCHEMBL6711877 0.91 PTK2B (0.40) PLCG2POLBLMNAMAPTTP53
SCHEMBL6714268 0.91 LMNA (0.39) PLCG2POLBLMNAMAPTTP53
SCHEMBL6712028 0.91 MAP3K5 (0.38) PLCG2POLBLMNAMAPTTP53
SCHEMBL6710112 0.90 MAP3K5 (0.45) PLCG2POLBLMNAMAPTTP53
SCHEMBL6707825 0.90 HDAC3 (0.42) PLCG2POLBLMNAMAPTTP53
SCHEMBL6709327 0.90 MEN1 (0.44) PLCG2POLBLMNAMAPTTP53

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20040142981-A1 Antibacterial benzoic acid derivatives PHARMACIA & UPJOHN COMPANY 2004-07-22 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040142981-A1 Antibacterial benzoic acid derivatives GABRD, PHB1, GABBR1 PLCG2 4289/4885POLB 626/4885LMNA 4062/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.